Regeneron Pharmaceuticals Inc.

NMS : REGN
Pharmaceuticals
Tarrytown NY
Revenue (US$ Millions)$2,820
Revenue Growth (%)33.96%
Net Income (Millions)$348
Common Shares Outstanding (Millions)$102
Earnings per Share$3.07
Price To Earnings Ratio125.71
Total Equity (Millions)$2,542
Profit Margin 112.34%
Return on Equity17.83%
Long Term Debt (US$ Millions)$458
Debt To Equity Ratio (%)0.18%
Market Capitalization (US$ Millions)$42,022
Total Assets (US$ Millions)$3,872
Return on Assets (%)11.8
Current Assets (US$ Millions)$2,167
Inventories (US$ Millions)$129
Current Liabilities (US$ Millions)$655
Cost of Goods Sold (US$ Millions)$205
Asset Turnover0.73
Inventory Turnover2.06